Bronchiolitis obliterans syndrome
A review of bronchiolitis obliterans syndrome and therapeutic strategies
... Lung transplantation is a treatment option for patients with advanced lung disease or irreversible pulmonary failure. Despite advancements in surgical techniques, lung preservation, immunosuppression, and manage- ment of ...
9
Original Article Effects of azithromycin therapy on bronchiolitis obliterans syndrome after lung transplant: a meta-analysis
... transplantation. Bronchiolitis obliterans syndrome is a major feature and the most com- mon form of obstructive CLAD, which is clini- cally defined as a progressive decline (20% or more) in forced ...
7
Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
... Bronchiolitis obliterans syndrome (BOS) is a chronic graft-ver- sus-host disease (cGVHD) of the lung that develops after allo- geneic hematopoietic stem cell transplantation ...
8
Bronchiolitis Obliterans Syndrome and Death in Iranian Lung Transplant Recipients: A Bayesian Competing Risks Analysis
... Bronchiolitis Obliterans Syndrome and Death in Iranian Lung Transplant Recipients: A Bayesian Competing Risks Analysis.. Fatemeh Sadat Hosseini-Baharanchi 1 ,.[r] ...
6
Critical role for the chemokine MCP 1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
... Bronchiolitis obliterans syndrome (BOS) is the major limitation to survival after lung transplanta- tion. Acute rejection, its main risk factor, is characterized by perivascular/bronchiolar leukocyte ...
11
Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome
... of bronchiolitis obliterans syndrome (BOS) and mortality after lung transplantation (LTx) for the two different time periods 1990 – 2002 and 2003 – ...
8
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome
... These diseases are characterized by chronic inflammation and fibroproliferation associated Nonstandard abbreviations used: BALF, bronchoalveolar lavage fluid; BOS, bronchiolitis oblitera[r] ...
14
Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation
... Idiopathic lung fibrosis (IPF) was the reason for trans- plantation in 22 patients. Following the official American Thoracic Society Statement, IPF was defined as chronic, progressive fibrosing interstitial pneumonia of ...
10
Long-term effect of azithromycin in bronchiolitis obliterans syndrome
... In conclusion, long-term treatment with azithromycin initially improves lung function then slows down the progression of BOS, although the effect of TLI may have affected the observed[r] ...
5
Azithromycin for treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients
... tis obliterans syndrome (BOS) is a major subtype of the recently termed Chronic Lung Allograft Dysfunction (CLAD) or late graft failure after lung ...
15
Mesenchymal stem cell pretreatment of non-heart-beating-donors in experimental lung transplantation
... Although lung transplantation has been proven to be an effective standard therapy for patients with different end- stage pulmonary diseases, significant scarcity of suitable donor organs [1] still limits an unrestricted ...
11
Extracorporeal life support as bridge to lung transplantation: a systematic review
... distress syndrome; BOS: bronchiolitis obliterans syndrome; CA: cardiac arrest; CF: cystic fibrosis; CIP/CIM: critical illness polyneuropathy/critical illness myopathy; COPD: chronic ...
10
The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation
... for bronchiolitis obliterans syndrome (BOS) was effective, which is the only single patho- pneumonic manifestation of cGVHD according to the National Institutes of Health (NIH) [91, ...
9
Human adipose-derived mesenchymal stem cells alleviate obliterative bronchiolitis in a murine model via IDO
... Lung transplantation offers the only hope for survival in many end-stage pulmonary diseases. According to the of- ficial International Society for Heart and Lung Transplant- ation (ISHLT) Registry Report of 2015, the ...
15
The aging lung: tissue telomere shortening in health and disease
... into bronchiolitis obliterans syndrome (BOS) (n = 11) and restrictive allograft syndrome (RAS) (n = 14), were collected during re-LTx or ...
10
Chemokine mediated angiogenesis: an essential link in the evolution of airway fibrosis?
... fibrosis. Bronchiolitis obliterans syndrome is a fibrotic occlusion of distal airways that is largely responsible for the morbidity and mortality of patients after lung ...
5
LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats
... simulate bronchiolitis obliterans after clinical lung ...in bronchiolitis obliterans after pulmonary ...of bronchiolitis obliterans after lung ...
6
Successful Treatment of Bronchiolitis Obliterans in a Bone Marrow Transplant Patient With Tumor Necrosis Factor-α Blockade
... lymphocytic bronchiolitis to organizing and organized phases of subepithelial fibrosis in con- strictive and obliterative bronchiolitis, it is likely that the timing of therapy early in the course of ...
6
Bronchiolitis obliterans associated with Stevens-Johnson Syndrome: histopathological bronchial reconstruction of the whole lung and immunohistochemical study
... ocular syndrome and causes severe erythema exsudativum multiform ...The syndrome is caused by many drugs, including antibiotics or antiepileptic, as well as by infection such as viruses or mycoplasma ...
6
Bronchiolitis Obliterans Organizing Pneumonia Due to Gastroesophageal Reflux
... of bronchiolitis obliterans organizing pneumonia (BOOP) are connective tissue diseases, organ transplantation, drug reaction, and ...artery syndrome and Helicobacter pylori infection, and the other ...
6